NASDAQ
Fennec Pharmaceuticals Inc. (FENC) has a price/sales ratio of 4.93x as of Friday, May 22, 2026. This represents a 89.17% decrease compared to its 12-month average of 45.50x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.